ES2195655T3 - Procedimiento para tratar fiebre hemorragica virica con proteina c. - Google Patents

Procedimiento para tratar fiebre hemorragica virica con proteina c.

Info

Publication number
ES2195655T3
ES2195655T3 ES99965808T ES99965808T ES2195655T3 ES 2195655 T3 ES2195655 T3 ES 2195655T3 ES 99965808 T ES99965808 T ES 99965808T ES 99965808 T ES99965808 T ES 99965808T ES 2195655 T3 ES2195655 T3 ES 2195655T3
Authority
ES
Spain
Prior art keywords
protein
fever
hemorragical
viric
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99965808T
Other languages
English (en)
Spanish (es)
Inventor
Charles Jack Fisher
Sau-Chi Betty Yan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2195655T3 publication Critical patent/ES2195655T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES99965808T 1998-11-20 1999-11-15 Procedimiento para tratar fiebre hemorragica virica con proteina c. Expired - Lifetime ES2195655T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10915398P 1998-11-20 1998-11-20

Publications (1)

Publication Number Publication Date
ES2195655T3 true ES2195655T3 (es) 2003-12-01

Family

ID=22326085

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99965808T Expired - Lifetime ES2195655T3 (es) 1998-11-20 1999-11-15 Procedimiento para tratar fiebre hemorragica virica con proteina c.

Country Status (12)

Country Link
US (2) US6270764B1 (https=)
EP (1) EP1131091B1 (https=)
JP (1) JP2002530353A (https=)
CN (1) CN1326356A (https=)
AT (1) ATE235915T1 (https=)
AU (1) AU2149800A (https=)
BR (1) BR9915460A (https=)
CA (1) CA2351470A1 (https=)
DE (1) DE69906568T2 (https=)
ES (1) ES2195655T3 (https=)
IL (1) IL142220A0 (https=)
WO (1) WO2000030677A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2351470A1 (en) * 1998-11-20 2000-06-02 Charles Jack Fisher Method of treating viral hemorrhagic fever
WO2002024215A2 (en) * 2000-09-18 2002-03-28 Eli Lilly And Company Method for using activated protein c for the treatment of coagulation-associated disorders
EA200400548A1 (ru) 2001-10-15 2005-06-30 Чирон Корпорейшн Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)
US7132398B2 (en) 2003-05-06 2006-11-07 Dendreon Corporation Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor
EP1729791A2 (en) * 2004-03-17 2006-12-13 Chiron Corporation Treatment of severe community-acquired pneumonia by admistration of tissue factor pathway inhibitor (tfpi)
WO2007092607A2 (en) * 2006-02-09 2007-08-16 Genetech, Inc. Treatment of hemorrhagic viral infections using a tissue factor inhibitor
RU2379034C1 (ru) * 2008-11-17 2010-01-20 Государственное образовательное учреждение высшего профессионального образования "Мордовский государственный университет им. Н.П. Огарева" Способ лечения геморрагической лихорадки с почечным синдромом
EP3551198B1 (en) * 2016-12-08 2022-02-02 Cellphire Inc. Compositions and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
CA3121200A1 (en) 2018-11-30 2020-06-04 Cellphire, Inc. Platelets as delivery agents
WO2020112963A1 (en) 2018-11-30 2020-06-04 Cellphire, Inc. Platelets as delivery agents
IL322149A (en) 2019-05-03 2025-09-01 Cellphire Inc Materials and methods for manufacturing blood products
CN114450066A (zh) 2019-08-16 2022-05-06 塞尔菲乐有限公司 作为抗血小板剂逆转剂的血栓小体
CA3170196A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Anti-fibrinolytic loaded platelets
TW202245814A (zh) 2021-02-17 2022-12-01 美商賽菲爾公司 用於治療抗血小板誘導的凝血病之凍乾血小板衍生物組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
US5516650A (en) 1985-06-27 1996-05-14 Zymogenetics, Inc. Production of activated protein C
US5550036A (en) 1986-04-09 1996-08-27 Eli Lilly And Company Method for co-amplification of human protein C genes in human cells
US4992373A (en) 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
US4981952A (en) 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
IL97312A (en) 1990-02-23 1999-01-26 Lilly Co Eli A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient
US5506134A (en) * 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
AT402262B (de) 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
MY110664A (en) 1992-05-21 1999-01-30 Lilly Co Eli Protein c derivatives
WO1997020043A1 (en) 1995-11-30 1997-06-05 Zymogenetics, Inc. Protein c production in transgenic animals
CZ298429B6 (cs) * 1997-04-28 2007-10-03 Eli Lilly And Company Stabilní lyofilizovaný prostredek
CA2351470A1 (en) * 1998-11-20 2000-06-02 Charles Jack Fisher Method of treating viral hemorrhagic fever
EP1090130A1 (en) * 1999-04-30 2001-04-11 Eli Lilly And Company Protein c derivatives

Also Published As

Publication number Publication date
CN1326356A (zh) 2001-12-12
US20010028880A1 (en) 2001-10-11
US6270764B1 (en) 2001-08-07
US6767539B2 (en) 2004-07-27
EP1131091A1 (en) 2001-09-12
DE69906568T2 (de) 2004-02-12
AU2149800A (en) 2000-06-13
DE69906568D1 (de) 2003-05-08
EP1131091B1 (en) 2003-04-02
ATE235915T1 (de) 2003-04-15
WO2000030677A1 (en) 2000-06-02
JP2002530353A (ja) 2002-09-17
CA2351470A1 (en) 2000-06-02
BR9915460A (pt) 2001-07-17
IL142220A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
ATE234092T1 (de) 2-alkylpyrrolidine
ES2195655T3 (es) Procedimiento para tratar fiebre hemorragica virica con proteina c.
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
ES2124461T3 (es) Derivados de oxalilamino-benzofurano y de benzotienilo.
ES520340A0 (es) Un procedimiento para la preparacion de diarilpirazinas o triazinas.
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
EA199800667A1 (ru) Новые фенантридины
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
SV1995000007A (es) Derivados del acido micofenolico 5-substituidos.
DK0840606T3 (da) Små di- og trivalente molekyler som selectininhibitorer
BG102644A (bg) Подобрени концентрирани инжекционни и инфузионниразтвори за интравазално прилагане
BR9812357A (pt) Tratamento de distúbio oposicional desafiador
EA200000978A1 (ru) Противоопухолевая композиция, содержащая синергическую комбинацию производного антрациклина и производного камптотецина
PT1300084E (pt) Composicaio para o tratamento de insuficiencias venosas cronicas melha.
ES2079068T3 (es) 2-amino-6-fenil-4h-piran-4-onas antiateroscleroticas y antitromboticas.
TR200002203T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
ATE215084T1 (de) Imidazopyridin-azolidinone
DK0571457T3 (da) Iloprost med virkning overfor cerebral malaria.
BR9915317A (pt) Método de tratar trombocitopenia induzida por heparina
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
BR9915572A (pt) Processo de tratamento de doença de célula falciforme e talassemia
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
BR9915984A (pt) Método de tratar púrpura trombocitopênica e sìndrome urêmica hemolìtica